Clinical Trial Update: Gut Hormones as Mediators of Different Weight Loss Responses After Roux-en-Y Gastric Bypass [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating gut hormones as mediators of weight loss variability after Roux-en-Y gastric bypass, exploring biological factors be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Bariatric Surgery (Gastric Bypass), Severe Obesity | Phase 4 | Status: UNKNOWN